At the 2023 ACOG Annual Clinical & Scientific Meeting, a study on whether telemedicine contributes to patient adherence and satisfaction for gynecologic visits.
The COVID-19 pandemic revolutionized health care in a number of ways, from unprecedented rapid delivery of vaccines to market to an explosion in the use of telemedicine for patient-clinician visits. Telemedicine became essential during the pandemic, in order to continue delivery of important health services, and today is still being used on a regular basis. And, while the efficacy of telemedicine has been studied in a number of disciplines, there is little data on patient satisfaction in telehealth visits with regards to gynecology.
Lead investigator Sue Junn, BS, University of Maryland School of Medicine, Baltimore, together with Andrea Desai, MD, assistant professor, maternal fetal medicine, University of Maryland School of Medicine, and several other researchers, evaluated how telemedicine impacts patients in regards to adherence and satisfaction during a gynecologic visit.
The researchers conducted a retrospective review of 1170 patients who participated in telemedicine visits as well as 5303 patients who visited their practitioners in person between March 1, 2020, and December 1, 2021. Investigators evaluated demographic info, the chief reason for the visit, and attendance. A cross-sectional survey of 1248 patients who participated in the telemedicine visits was used to evaluate patient satisfaction, access, quality, safety, and convenience.
Results proved to be significantly disparate: There was an average no-show rate of 22% for in-person visits, as opposed to a 2% no-show rate for telemedicine patients. Additionally, 69% of survey respondents reported satisfaction with telehealth visits.
Investigators concluded that these higher percentage rates for telehealth visits may reflect patients’ satisfaction with convenience, time-efficiency, and a less disruptive day overall.
Reference
Junn S, Desai A, Hurvitz J, Lahti E.Assessing the impact of telemedicine implementation on patient satisfaction with and adherence to gynecologic appointments. 2023 ACOG Annual Clinical & Scientific Meeting. May 19-21. Baltimore, Maryland.
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More
Study finds link Between RBC transfusion and anemia in placenta accreta spectrum
May 8th 2024Investigating the impact of red blood cell transfusions on peripartum complications and anemia risk highlights the importance of prepartum anemia detection in women diagnosed with placenta accreta spectrum.
Read More
Impact of weight, ferritin, and nutrition education on postpartum depression risk
May 7th 2024A recent study highlights the role of weight gain, ferritin levels, and nutritional education in influencing the risk of postpartum depression among pregnant women, urging for proactive measures during routine prenatal care.
Read More
Postmenopausal urinary incontinence treatment data found lacking
May 6th 2024Discover the findings of a comprehensive study exploring the efficacy of various treatments for postmenopausal urinary incontinence, shedding light on the current research gap and recommending avenues for future investigation.
Read More